KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Return on Capital Employed (2016 - 2025)

NovoCure's Return on Capital Employed history spans 11 years, with the latest figure at 0.18% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 18.0% year-over-year to 0.18%; the TTM value through Dec 2025 reached 0.18%, up 18.0%, while the annual FY2025 figure was 0.19%, 20.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.18% at NovoCure, up from 0.33% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.04% in Q1 2021 and bottomed at 0.36% in Q4 2024.
  • The 5-year median for Return on Capital Employed is 0.18% (2024), against an average of 0.17%.
  • The largest annual shift saw Return on Capital Employed dropped -16bps in 2023 before it rose 18bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.04% in 2021, then tumbled by -95bps to 0.09% in 2022, then plummeted by -175bps to 0.24% in 2023, then plummeted by -49bps to 0.36% in 2024, then surged by 50bps to 0.18% in 2025.
  • Per Business Quant, the three most recent readings for NVCR's Return on Capital Employed are 0.18% (Q4 2025), 0.33% (Q3 2025), and 0.35% (Q2 2025).